2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9978):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-10218S1
    Everolimus-13C2,d4
    Everolimus-13C2,d4 (RAD001-13C2,d4) is 13C labeled Everolimus. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities.
    Everolimus-<sup>13</sup>C<sub>2</sub>,d<sub>4</sub>
  • HY-157056S
    5α-Estran-3β-ol-17-one-d3
    5α-Estran-3β-ol-17-one-d3 is deuterium-labeled 5α-Estran-3β-ol-17-one.
    5α-Estran-3β-ol-17-one-d<sub>3</sub>
  • HY-139461S
    5-Acetylamino-6-formylamino-3-methyluracil-d3
    5-Acetylamino-6-formylamino-3-methyluracil-d3 is the deuterium labeled 5-Acetylamino-6-formylamino-3-methyluracil.
    5-Acetylamino-6-formylamino-3-methyluracil-d<sub>3</sub>
  • HY-14773S3
    Mirabegron-d5
    Mirabegron-d5 (YM178-d5) is deuterium labeled Mirabegron. Mirabegron is a selective β3-adrenoceptor agonist with EC50 of 22.4 nM.
    Mirabegron-d<sub>5</sub>
  • HY-W440436S
    2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol-d4
    2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol-d4 is deuterium labeled 2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol.
    2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol-d<sub>4</sub>
  • HY-14149S
    Cisapride-d6
    Cisapride-d6 (R51619-d6) is deuterium labeled Cisapride. Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity.
    Cisapride-d<sub>6</sub>
  • HY-165678S
    (±)-10-Hydroxy-12(Z)-Octadecenoic acid-d5
    (±)-10-Hydroxy-12(Z)-Octadecenoic acid-d5 (10-Hydoxy-cis-12-Octadeceoic Acid-d5) is deuterium labeled (±)-10-Hydroxy-12(Z)-Octadecenoic acid.
    (±)-10-Hydroxy-12(Z)-Octadecenoic acid-d<sub>5</sub>
  • HY-W742014
    Hydroxymethyl clenbuterol-d6
    Hydroxymethyl clenbuterol-d6 is deuterium labeled Hydroxymethyl Clenbuterol.
    Hydroxymethyl clenbuterol-d<sub>6</sub>
  • HY-132344S
    N-Desmethyl asenapine-d4 hydrochloride
    N-Desmethyl asenapine-d4 (hydrochloride) is the deuterium labeled N-Desmethyl asenapine hydrochloride.
    N-Desmethyl asenapine-d<sub>4</sub> hydrochloride
  • HY-109854S
    (S)-Lisofylline-d5
    (S)-Lisofylline-d5 ((S)-Lisophylline-d5) is the deuterium labeled (S)-Lisofylline (HY-109854). (S)-Lisofylline is a kind of Lisofline enantiomer with optical activity. (S)-Lisofylline can interconversion with pentoxifylline.
    (S)-Lisofylline-d<sub>5</sub>
  • HY-W722289S
    (rac)-Metolachlor metabolite CGA 50267-d3
    (rac)-Metolachlor metabolite CGA 50267-d3 (N-(2-(Ethyl-2,2,2-d3)-6-methylphenyl)-2-aminopropanoic acid) is deuterium labeled (2-Ethyl-6-methylphenyl)alanine.
    (rac)-Metolachlor metabolite CGA 50267-d<sub>3</sub>
  • HY-173107S
    Haemoglobin HbA0 (a2b2), U-15N
    Haemoglobin HbA0 (a2b2), U-15N is the 15N-labeled Haemoglobin Haemoglobin HbA0 (a2b2), U.
    Haemoglobin HbA0 (a2b2), U-<sup>15</sup>N
  • HY-107333S
    Cinoxate-d3
    Cinoxate-d3 is deuterium labeled Cinoxate. Cinoxate is a hypertrophic peroxisome proliferator activating receptor γ (PPARγ) agonist with Ki value of 18.0 μM. Cinoxate can be used to study obesity.
    Cinoxate-d<sub>3</sub>
  • HY-14885S2
    Eliglustat-d15
    Eliglustat-d15 (Genz 99067-d15) is deuterium labeled Eliglustat. Eliglustat is an specific, potent and orally active glucocerebroside synthase inhibitor with an IC50 of 24 nM.
    Eliglustat-d<sub>15</sub>
  • HY-23331S
    4-Methylimidazolidine-2-thione-d3
    4-Methylimidazolidine-2-thione-d3 is deuterium labeled 4-Methylimidazolidine-2-thione.
    4-Methylimidazolidine-2-thione-d<sub>3</sub>
  • HY-W106835S1
    N-(3-Hydroxybenzyl)adenosine-15N,d2
    N-(3-Hydroxybenzyl)adenosine-15N,d2 is 15N and deuterium labeled N-(3-Hydroxybenzyl)adenosine.
    N-(3-Hydroxybenzyl)adenosine-<sup>15</sup>N,d<sub>2</sub>
  • HY-12365S2
    Tauro-obeticholic acid-d5
    Tauro-obeticholic acid-d5 is deuterium labeled Tauro-obeticholic acid (HY-135399). Tauro-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an orally bioavailable farnesoid-X receptor (FXR) agonist.
    Tauro-obeticholic acid-d<sub>5</sub>
  • HY-15307S
    Belumosudil-d7
    Belumosudil-d7 (KD025-d7) is deuterium labeled Belumosudil. Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 μM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties.
    Belumosudil-d<sub>7</sub>
  • HY-B0458AS
    Cefprozil-d4
    Cefprozil-d4 is the deuterium labeled Cefprozi (HY-B0458A). Cefprozil is a second-generation cephalosporin type antibiotic. Cefprozil exhibits broad-spectrum antibacterial activity, and is orally active. Cefprozil can be used for the study of pharyngitis, tonsillitis, otitis media, and uncomplicated skin infections.
    Cefprozil-d<sub>4</sub>
  • HY-125033S1
    EIDD-1931-d2
    EIDD-1931-d2 is the deuterium labeled 3,6-Dichloro-2-methoxybenzoic acid.
    EIDD-1931-d<sub>2</sub>